Mykito Sciences

Startup
United States
Summarized by Halo AI

Mykito Sciences is a biotechnology company that manufactures medical-grade, non-animal chitosan using proprietary fermentation technology for use in pharmaceutical, medical device, and wound care applications.

Founded & HQ
San Marino, CA, USA
Company size
1-10 employees
IP status
1 patent filed · 1 grant confirmed
Activity highlights
Awarded the Early-Stage Growth Grant (EGG) funding and relocated from California to the Innovation Space at the Experimental Station in Wilmington, Delaware.

Mykito Sciences specializes in the production of high-purity, non-animal chitosan utilizing a proprietary fermentation technology. By focusing on precision biomanufacturing, the company produces material that is designed to be free from common contaminants like beta-glucans and heavy metals found in traditional sources. Their production process is governed by a GMP-compliant quality system in ISO 22000-certified facilities, which ensures traceability, performance consistency, and adherence to the stringent regulatory requirements necessary for high-stakes applications.

This technology provides essential value to customers in the medical, pharmaceutical, and wound care sectors, where material purity and consistency are critical for safety and product performance. By offering a non-animal-derived alternative, Mykito Sciences helps developers of medical devices and pharmaceutical excipients reduce regulatory burdens and improve the reliability of their own supply chains. The company serves industrial, food, and life science markets with solutions intended to support advanced applications such as tissue regeneration and biologic-grade material requirements.

AI summary generated on Jul 8, 2026
OpenAlexOpenAlex

For general inquiries

Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.

Looking for

Co-developmentLicensingPilot or trial engagement

Key links

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.